1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Refractory or Relapsed Solid Tumors: new trials by email Literature Review of Refractory or Relapsed Solid Tumors trials Research Report on Refractory or Relapsed Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors Sorafenib combined with Hydroxychloroquine - Refractory or Relapsed Solid Tumors | Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 18 | 2012-06-01 | 2016-03-25 |
The University of Texas Health Science Center at San Antonio (1)
United States (1)